Global drugmaker Novartis will lay off 427 employees in East Hanover this spring and summer, after it let go of 235 at the ...
EAST HANOVER, NJ, USA I March 20, 2025 I Novartis today announced that oral Fabhalta® (iptacopan) has received U.S. Food and Drug Administration (FDA) ...
Swiss pharma major Novartis (NOVN: VX) is set to lay off 427 employees at its East Hanover, New Jersey, site as part of a ...
By 2013, over 125,000 people worked for Novartis – 47% in Europe, 24% in Africa, Asia and Australia, 21% in the USA and 8% in Canada and Latin America. The main portion of employees (over 60,000 ...
A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...
CARVYKTI® net trade sales of approximately $334 million and $963 million for the fourth quarter and full year 2024, respectivelyOver 5,000 patients treated to dateInitiated commercial production of CA ...
Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.
Cambridge, USA-based clinical-stage oncology company Immuneering (Nasdaq: IMRX) announced the appointment of Dr Igor ...
Campaign Middle East on MSN11d
TBWA\Raad appoints Derek Green as Chief Creative OfficerDerek Green has led award-winning campaigns for global brands, including Verizon, Samsung, KFC, Novartis, P&G, Coca-Cola, ...
Acquires natural products and genetic strains assets from Novartis to boost biologicals research Inaugurates cutting-edge production facility in South Carolina, USA Biologicals portfolio to help ...
Celltrion’s Omlyclo is interchangeable with Xolair to treat the same conditions: asthma, chronic rhinosinusitis, food allergy ...
CAMBRIDGE, MA, USA I March 11, 2025 I Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback